These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 22564703)

  • 1. Insulin-like growth factor I (Igf-1) gene polymorphism in patients with non-metastatic breast cancer.
    Yaren A; Turgut S; Ayada C; Akcilar R; Degirmencioglu S; Gokoz Dogu G
    Gene; 2012 Jul; 503(2):244-7. PubMed ID: 22564703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue.
    Chong KY; Subramanian A; Mokbel K; Sharma AK
    J Surg Oncol; 2011 Sep; 104(3):228-35. PubMed ID: 21480260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
    Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
    Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-1 CA repeat variant and breast cancer risk in postmenopausal women.
    González-Zuloeta Ladd AM; Liu F; Houben MP; Arias Vásquez A; Siemes C; Janssens AC; Coebergh JW; Hofman A; Janssen JA; Stricker BH; van Duijn CM
    Eur J Cancer; 2007 Jul; 43(11):1718-22. PubMed ID: 17561390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.
    Tsuchiya N; Wang L; Suzuki H; Segawa T; Fukuda H; Narita S; Shimbo M; Kamoto T; Mitsumori K; Ichikawa T; Ogawa O; Nakamura A; Habuchi T
    J Clin Oncol; 2006 May; 24(13):1982-9. PubMed ID: 16648498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of insulin-like growth factor II in female breast cancer as related to established prognostic factors and long-term prognosis.
    Toropainen EM; Lipponen PK; Syrjanen KJ
    Anticancer Res; 1995; 15(6B):2669-74. PubMed ID: 8669844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival.
    Shin A; Ren Z; Shu XO; Cai Q; Gao YT; Zheng W
    Breast Cancer Res Treat; 2007 Sep; 105(1):55-61. PubMed ID: 17066319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of protease activated receptor 1 gene -506 I/D polymorphism with disease-free survival in breast cancer patients.
    Eroğlu A; Karabıyık A; Akar N
    Ann Surg Oncol; 2012 Apr; 19(4):1365-9. PubMed ID: 21822552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
    Wagner K; Hemminki K; Israelsson E; Grzybowska E; Söderberg M; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Försti A
    Breast Cancer Res Treat; 2005 Jul; 92(2):133-40. PubMed ID: 15986122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women.
    Figer A; Karasik YP; Baruch RG; Chetrit A; Papa MZ; Sade RB; Rizel S; Friedman E
    Isr Med Assoc J; 2002 Oct; 4(10):759-62. PubMed ID: 12389335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I gene and insulin-like growth factor binding protein-3 polymorphism in patients with thyroid dysfunction.
    Kursunluoglu R; Turgut S; Akin F; Bastemir M; Kaptanoglu B; Genc O; Turgut G
    Arch Med Res; 2009 Jan; 40(1):42-7. PubMed ID: 19064126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma.
    Snoussi K; Strosberg AD; Bouaouina N; Ben Ahmed S; Chouchane L
    Eur Cytokine Netw; 2005 Dec; 16(4):253-60. PubMed ID: 16464738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer.
    Mita K; Zhang Z; Ando Y; Toyama T; Hamaguchi M; Kobayashi S; Hayashi S; Fujii Y; Iwase H; Yamashita H
    Jpn J Clin Oncol; 2007 Aug; 37(8):575-82. PubMed ID: 17675285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
    Diorio C; Brisson J; Bérubé S; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin expression predicts early recurrence in early-stage breast cancer.
    Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
    Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery.
    Sancak B; Coskun U; Gunel N; Onuk E; Cihan A; Karamercan A; Yildirim Y; Ozkan S
    Intern Med J; 2004 Jun; 34(6):310-5. PubMed ID: 15228391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of interleukin-10 gene variation with breast cancer prognosis.
    Gerger A; Renner W; Langsenlehner T; Hofmann G; Knechtel G; Szkandera J; Samonigg H; Krippl P; Langsenlehner U
    Breast Cancer Res Treat; 2010 Feb; 119(3):701-5. PubMed ID: 19437115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.